Staar surgical plans to end 2026 with well over $200M in cash while shifting 100% of China supply to Switzerland (NASDAQ:STAA)

seekingalpha.com · 2026-08-13

STAAR Surgical (STAA) Q2 2026 earnings call: China EVO Plus ramp, record revenue, margins, tariffs, and Q3 seasonality outlook.